CD38-targeted attenuated interferon alpha immunocytokine activates both innate and adaptive immune cells to drive anti-tumor activity

James F. Sampson(Takeda (Japan)), Michael D. Curley(Takeda (Japan))
PLoS ONE
May 2, 2025
Cited by 2


Related Papers